Related references
Note: Only part of the references are listed.High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors
Lawrence H. Einhorn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Proteomic analysis of cisplatin-induced cochlear damage: Methods and early changes in protein expression
Donald E. Coling et al.
HEARING RESEARCH (2007)
Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors
Jan Oldenburg et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HSP-70 as a nonspecific early marker in cisplatin ototoxicity
R. Ramirez-Camacho et al.
ACTA OTO-LARYNGOLOGICA (2007)
Management of recurrent testicular germ cell tumors
Guru Sonpavde et al.
ONCOLOGIST (2007)
Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: Possible role in apoptosis
Zejia Yang et al.
CLINICAL CANCER RESEARCH (2006)
Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
M. K. L. Fung et al.
BRITISH JOURNAL OF CANCER (2006)
Inner ear proteomics: A fad or hear to stay
Isolde Thalmann
BRAIN RESEARCH (2006)
Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig
A Ekborn et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2003)
Strategies for prevention of toxicity caused by platinum-based chemotherapy: Review and summary of the Annual Meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001
BW Blakley et al.
LARYNGOSCOPE (2002)